Designing Tomorrow´s Vaccines

SVF Vaccines develops vaccines and immunotherapies to prevent and treat life-threatening diseases based on technology developed at Karolinska Institute in Stockholm. Our most advanced program is a therapeutic vaccine for chronic hepatitis B and D infections, while Karolinska Institutet and the OpenCorona consortium are performing a Phase 1 study with SVF Vaccines' universal Covid-19 vaccine. Additional vaccines are in the discovery phase.